First pfas "forever chemicals" consumer-initiated blood test with physician consult launches on questhealth.com

Directed at individuals who may be at risk of elevated pfas exposure, the new test detects and measures pfas identified by national academies of sciences, engineering, and medicine organizations interested in workforce, community, and research population testing may also access the test secaucus, n.j. , feb. 12, 2024 /prnewswire/ -- quest diagnostics (nyse: dgx), the world's leader in diagnostic information services, today announced the availability of the first consumer-initiated, physician-ordered blood-draw test for pfas chemicals with the option to confer over the phone with a physician about the results.
DGX Ratings Summary
DGX Quant Ranking